Atrial natriuretic peptides in heart failure: Pathophysiological significance, diagnostic and prognostic value

Canadian Journal of Physiology and Pharmacology

Volumn 89, Issue 8, 2011, Pages 587-591

  Ghosh, Nina ^a   Haddad, Haissam ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Atrial natriuretic peptide; Brain natriuretic peptide; Heart failure; Renin angiotensin aldosterone system; Sympathetic nervous system

Indexed keywords

ADIPONECTIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CHROMOGRANIN A; PROADRENOMEDULLIN;

ADRENERGIC SYSTEM; CONGESTIVE CARDIOMYOPATHY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIURESIS; HEART FAILURE; HORMONE RELEASE; HUMAN; KIDNEY BLOOD FLOW; MORTALITY; NATRIURESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; VASODILATATION;

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; HEART FAILURE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS;

EID: 79961205525     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/y11-040     Document Type: Review

References (18)

1. Cogan, M.G. 1990. Atrial natriuretic peptide. Kidney Int. 37(4): 1148-1160. doi:10.1038/ki.1990.98. PMID:2160558.
2. Cohn, J.N. 1997. Current concepts in the treatment of congestive heart failure. Cardiology, 88(Suppl 2): 2-6. doi:10.1159/000177477. PMID:9142429.
3. Cohn, J.N., Levine, T.B., Olivari, M.T., Garberg, V., Lura, D., Francis, G.S., et al. 1984. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N. Engl. J. Med. 311(13): 819-823. doi:10.1056/NEJM198409273111303. PMID:6382011.
4. Dieplinger, B., Gegenhuber, A., Haltmayer, M., and Mueller, T. 2009. Evaluation of novel biomarkers for the diagnosis of acute destabilised heart failure in patients with shortness of breath. Heart, 95(18): 1508-1513. doi:10.1136/hrt.2009.170696. PMID: 19525245.
5. Dzau, V.J. 1993. Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch. Intern. Med. 153(8): 937-942. doi:10.1001/archinte.153.8.937. PMID:8386920.
6. Francis, G.S., Goldsmith, S.R., Levine, T.B., Olivari, M.T., and Cohn, J.N. 1984. The neurohumoral axis in congestive heart failure. Ann. Intern. Med. 101(3): 370-377. PMID:6147109.
7. Gegenhuber, A., Struck, J., Dieplinger, B., Poelz, W., Pacher, R., Morgenthaler, N.G., et al. 2007. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure. J. Card. Fail. 13(1): 42-49. doi:10.1016/j.cardfail.2006.09.004. PMID: 17339002.
8. Maisel, A.S., Peacock, W.F., McMullin, N., Jessie, R., Fonarow, G. C., Wynne, J., and Mills, R.M. 2008. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis. J. Am. Coll. Cardiol. 52 (7): 534-540. doi:10.1016/j.jacc.2008.05.010. PMID:18687247.
9. Maisel, A., Mueller, C., Nowak, R., Peacock, W.F., Landsberg, J. W., Ponikowski, P., et al. 2010. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J. Am. Coll. Cardiol. 55(19): 2062-2076. doi:10.1016/j.jacc.2010.02.025. PMID:20447528.
10. Moertl, D., Berger, R., Struck, J., Gleiss, A., Hammer, A., Morgenthaler, N.G., et al. 2009. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death. J. Am. Coll. Cardiol. 53(19): 1783-1790. doi:10.1016/j.jacc.2009.01.057. PMID:19422985.
11. Morgenthaler, N.G., Struck, J., Thomas, B., and Bergmann, A. 2004. Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. Clin. Chem. 50(1): 234-236. doi:10.1373/clinchem.2003.021204. PMID:14709661.
12. Mukoyama, M., Nakao, K., Hosoda, K., Suga, S., Saito, Y., Ogawa, Y., et al. 1991. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J. Clin. Invest. 87(4): 1402-1412. doi:10.1172/ JCI115146. PMID:1849149.
13. Potocki, M., Breidthardt, T., Reichlin, T., Hartwiger, S., Morgentha-ler, N.G., Bergmann, A., et al. 2010. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriure-tic peptide in the diagnosis of heart failure. J. Intern. Med. 267(1): 119-129. doi:10.1111/j.1365-2796.2009.02135.x. PMID: 19570053.
14. Suttner, S.W., and Boldt, J. 2004. Natriuretic peptide system: physiology and clinical utility. Curr. Opin. Crit. Care, 10(5): 336-341. doi:10.1097/01.ccx.0000135513.26376.4f. PMID: 15385748.
15. Weidmann, P., Hasler, L., Gnädinger, M.P., Lang, R.E., Uehlinger, D. E., Shaw, S., et al. 1986. Blood levels and renal effects of atrial natriuretic peptide in normal man. J. Clin. Invest. 77(3): 734-742. doi:10.1172/JCI112368. PMID:2936762.
16. Yasue, H., Yoshimura, M., Sumida, H., Kikuta, K., Kugiyama, K., Jougasaki, M., et al. 1994. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation, 90(1): 195-203. PMID:8025996.
17. Yoshimura, M., Yasue, H., Okumura, K., Ogawa, H., Jougasaki, M., Mukoyama, M., et al. 1993. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation, 87(2): 464-469. PMID: 8425293.
18. Yoshimura, M., Yasue, H., and Ogawa, H. 2001. Pathophysiological significance and clinical application of ANP and BNP in patients with heart failure. Can. J. Physiol. Pharmacol. 79(8): 730-735. doi:10.1139/y01-039. PMID:11558682.